MARTORANA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 29.089
AS - Asia 3.201
EU - Europa 2.552
SA - Sud America 490
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 12
Totale 35.401
Nazione #
US - Stati Uniti d'America 29.018
SG - Singapore 1.831
CN - Cina 532
IT - Italia 489
DE - Germania 420
BR - Brasile 411
UA - Ucraina 389
HK - Hong Kong 341
IE - Irlanda 294
RU - Federazione Russa 198
FR - Francia 149
GB - Regno Unito 148
VN - Vietnam 144
KR - Corea 130
SE - Svezia 102
FI - Finlandia 92
PL - Polonia 88
NL - Olanda 73
CA - Canada 38
AR - Argentina 32
JP - Giappone 32
AT - Austria 30
IN - India 30
BD - Bangladesh 25
ID - Indonesia 24
MX - Messico 21
TR - Turchia 20
ES - Italia 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 17
EC - Ecuador 17
BE - Belgio 16
UZ - Uzbekistan 16
KG - Kirghizistan 14
EU - Europa 12
IQ - Iraq 12
AU - Australia 11
CL - Cile 11
KE - Kenya 9
SA - Arabia Saudita 8
PY - Paraguay 7
PK - Pakistan 6
MA - Marocco 5
CH - Svizzera 4
GR - Grecia 4
PH - Filippine 4
VE - Venezuela 4
BG - Bulgaria 3
CG - Congo 3
CO - Colombia 3
DO - Repubblica Dominicana 3
IL - Israele 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
DK - Danimarca 2
DM - Dominica 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
RO - Romania 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 35.401
Città #
Woodbridge 8.024
Wilmington 7.325
Houston 7.086
Fairfield 1.069
Singapore 736
Ann Arbor 667
Ashburn 545
Chandler 465
Seattle 427
Cambridge 342
Hong Kong 338
Jacksonville 329
Dublin 274
Beijing 271
Medford 217
Dearborn 211
Rome 179
New York 152
Santa Clara 129
Lawrence 102
Los Angeles 97
The Dalles 75
Munich 72
Kraków 62
San Diego 59
Buffalo 55
Ho Chi Minh City 51
Mülheim 51
Moscow 47
Menlo Park 43
Zhengzhou 42
Council Bluffs 39
Milan 38
São Paulo 38
Chicago 30
Dallas 29
Norwalk 29
London 28
Palo Alto 28
Hanoi 27
Redondo Beach 24
Warsaw 24
Atlanta 20
Nuremberg 20
Redwood City 20
Rio de Janeiro 20
Maastricht 19
Tokyo 19
Brooklyn 18
Vienna 18
Brussels 16
Hangzhou 16
Johannesburg 16
Brno 15
Verona 15
San Francisco 14
Stockholm 14
Columbus 13
Montreal 13
Phoenix 13
San Jose 13
Toronto 13
Turku 13
Falls Church 12
Hefei 12
Jakarta 12
Poplar 12
Seoul 12
Shanghai 12
University Park 12
Boardman 11
Denver 11
Guangzhou 11
Orem 11
Saint Petersburg 11
Tashkent 11
Amsterdam 10
Belo Horizonte 10
Brasília 10
Del Norte 10
Da Nang 9
Boston 8
Chennai 8
Dhaka 8
Guayaquil 8
Mexico City 8
Mountain View 8
Nairobi 8
San Mateo 8
Ankara 7
Baghdad 7
Campinas 7
Ferrara 7
Helsinki 7
Madrid 7
Manchester 7
Nanjing 7
Palermo 7
Salt Lake City 7
Biên Hòa 6
Totale 30.553
Nome #
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 576
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 500
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 491
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 480
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 471
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 470
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 468
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 466
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 462
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 451
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 450
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 448
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 446
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 445
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 442
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 442
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 440
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 438
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 438
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 438
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 435
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 434
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 433
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 432
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 431
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 431
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 430
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 429
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 425
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 424
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 424
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 424
Huntingtin distribution among striatal output neurons of normal rat brain 421
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 420
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 419
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 416
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 415
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 414
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 413
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 412
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 409
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 406
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 404
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 403
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 403
Tissue plasminogen activator is required for corticostriatal long-term potentiation 402
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 402
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 401
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 395
Plasmin system of Alzheimer's disease patients: CSF analysis 395
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 393
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 393
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 392
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 391
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 391
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 390
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 387
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 386
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 379
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 377
Frailty among Alzheimer's disease patients 374
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 373
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 373
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 369
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 357
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 357
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 354
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 352
Is dopamine involved in Alzheimer's disease? 349
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 343
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 340
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 339
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 326
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 291
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 284
Assessment of serum uric acid as risk factor for tauopathies 281
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 271
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 223
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 207
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 203
Alzheimer’s disease and the routine clinical use of CSF biomarkers 184
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 178
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 164
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 147
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 147
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 145
Insulin and the future treatment of Alzheimer’s disease 145
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 142
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 139
Ageing as a Trait de Union between diabetes and dementia for frailty 133
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 131
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 128
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 119
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 110
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 92
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 91
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 89
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 82
Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer's disease 80
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 77
Totale 34.532
Categoria #
all - tutte 84.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.079 0 0 0 0 0 523 605 506 106 122 177 40
2021/20221.167 55 158 86 37 32 114 55 88 71 80 73 318
2022/20231.285 144 111 45 131 100 297 109 58 114 16 109 51
2023/2024498 58 16 31 25 42 148 20 44 10 10 6 88
2024/20253.097 84 631 289 162 77 231 134 117 305 260 407 400
2025/20262.234 399 237 529 442 483 144 0 0 0 0 0 0
Totale 35.786